PharVision Advisers »

Archrock shares owned by PharVision Advisers

Quarter-by-quarter ownership of Archrock (AROC) shares owned by PharVision Advisers from 13F filings

Historical chart of PharVision Advisers investment in Archrock

Tip: Access up to 7 years of quarterly data

All positions including Archrock held by PharVision Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Archrock by PharVision Advisers

Quarter filed Position value Share count Share price at filing
2025-09-30 $317k 12k 26.31
2025-03-31 $205k 7.8k 26.24

More positions owned by PharVision Advisers

Wayfair Cl A (W)
ExlService Holdings (EXLS)
Up Fintech Hldg Sponsored Ads (TIGR)
Array Technologies Com Shs (ARRY)
Sprouts Fmrs Mkt (SFM)
Corporacion Amer Arpts S A (CAAP)
Vertiv Holdings Com Cl A (VRT)
Zevra Therapeutics Com New (ZVRA)
Bowhead Specialty Hldgs Com Shs (BOW)
Lexinfintech Hldgs Adr (LX)
Euronet Worldwide (EEFT)
Rigel Pharmaceuticals (RIGL)
Masimo Corporation (MASI)
LSB Industries (LXU)
Bright Horizons Fam Sol In D (BFAM)

View all positions for PharVision Advisers

Top funds holding Archrock

BlackRock
Vanguard Group
Earnest Partners
Invesco
State Street Corporation
Dimensional Fund Advisors
American Century Companies
Sei Investments
Geode Capital Management
FMR
Goldman Sachs Group
Citadel Advisors
Morgan Stanley
Charles Schwab Investment Management
Millennium Management

View all funds holding Archrock